Cencora (COR) Stock Insights
COR$330.53+6.18 +1.91%
$63.07B
Market Cap
23.99
P/E
16.75
Forward P/E
45
Score
Cencora (COR) Stock Insights
COR price $330.53 +6.18 +1.91%
- Ticker
- COR
- Price
- $330.53
- Change
- +6.18 +1.91%
- Market cap ?
- $63.07B
- P/E ?
- 23.99
- Forward P/E ?
- 16.75
- Dividend yield ?
- 0.74%
- Beta ?
- 0.58
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Stocklytics score
- 45
- Value
- 56
- Quality
- 32
- Growth
- 48
Stocklytics score rationale: value 56, quality 32, growth 48.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 146849686000 | 153143826000 | 167939635000 | 179589121000 | 189893926000 | 213988843000 | 238587006000 | 262173411000 | 293958599000 | 321332819000 |
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client…
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2012 | Intersegment Eliminations: -184482000.0, Other Segments: 1324744000.0, Pharmaceutical Distribution: 78349334000.0 |
| FY2013 | Intersegment Eliminations: -192332000.0, Other Segments: 1763549000.0, Pharmaceutical Distribution: 86387950000.0 |
| FY2014 | Intersegment Eliminations: -263989000.0, Other Segments: 2449149000.0, Pharmaceutical Distribution: 117383967000.0 |
| FY2015 | Other Segments: 4772178000.0, Pharmaceutical Distribution: 131480550000.0 |
| FY2016 | Other Segments: 6386917000.0, Pharmaceutical Distribution: 140731224000.0 |
| FY2017 | Other Segments: 5747863000.0, Pharmaceutical Distribution: 147453495000.0 |
| FY2018 | Other Segments: 6332730000.0, Pharmaceutical Distribution: 161699343000.0 |
| FY2019 | Animal Health: 3975232000.0, International Healthcare Solutions: 2893109000.0, Other Segments: 6868341000.0, Pharmaceutical Distribution: 172813537000.0 |
| FY2020 | Animal Health: 4216462000.0, International Healthcare Solutions: 3308640000.0, Other Segments: 7525102000.0, Pharmaceutical Distribution: 182467189000.0 |
| FY2021 | Animal Health: 4684417000.0, International Healthcare Solutions: 11290382000.0 |
| FY2022 | Animal Health: 4216462000.0, International Healthcare Solutions: 26491673000.0, Pharmaceutical Distribution: 182171487000.0 |
| FY2023 | Animal Health: 5042549000.0, International Healthcare Solutions: 27418679000.0, Pharmaceutical Distribution: 229716669000.0 |
| FY2024 | Animal Health: 5365518000.0, International Healthcare Solutions: 28627542000.0, Pharmaceutical Distribution: 259973909000.0 |
| FY2025 | Animal Health: 5694517000.0, International Healthcare Solutions: 30366323000.0, Pharmaceutical Distribution: 285287506000.0 |
| Period | Value |
|---|---|
| FY2012 | Other Segments: 1324744000.0 |
| FY2013 | Other Segments: 1763549000.0 |
| FY2014 | Other Segments: 2449149000.0 |
| FY2015 | Other Segments: 4772178000.0 |
| FY2017 | Other Segments: 5747863000.0 |
| FY2018 | Other Segments: 6332730000.0 |
| FY2019 | Other Segments: 6868341000.0 |
| FY2020 | Other Segments: 7525102000.0 |
| FY2021 | Other Segments: 15974799000.0 |
| FY2022 | International Healthcare Solutions: 26491673000.0, U.S. Healthcare Solutions: 186387949000.0 |
| FY2023 | International Healthcare Solutions: 27418679000.0, U.S. Healthcare Solutions: 234759218000.0 |
| FY2024 | International Healthcare Solutions: 28627542000.0, U.S. Healthcare Solutions: 265339427000.0 |
| FY2025 | International Healthcare Solutions: 30366323000.0, U.S. Healthcare Solutions: 290982023000.0 |
Insights · Dividends · Forecast · Financials · Learn